SCHEMBL8788122

SCHEMBL8788122

NS(=O)(=O)c1ccc2oncc2c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 1/20 0.47
▸ CA2 P00918 13/20 0.41
▸ CA1 P00915 11/20 0.41
▸ PKM P14618 2/20 0.39
▸ ALPL P05186 1/20 0.39
▸ ALPI P09923 1/20 0.39
▸ CA9 Q16790 11/20 0.39
▸ CA12 O43570 8/20 0.39
▸ CA4 P22748 4/20 0.39
▸ CA6 P23280 4/20 0.39
▸ CA5A P35218 4/20 0.39
▸ CA7 P43166 4/20 0.39
▸ CA14 Q9ULX7 4/20 0.39
▸ CA5B Q9Y2D0 4/20 0.39
▸ TDP1 Q9NUW8 1/20 0.38
▸ KMT2A Q03164 2/20 0.38
▸ KDM4E B2RXH2 1/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ GAA P10253 1/20 0.38
▸ MAPT P10636 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21233203 0.82 TRPM5 (0.42) LMNARAB9A
SCHEMBL30952445 0.82 TRPM5 (0.39) PKMTDP1KMT2AMEN1
SCHEMBL693306 0.82 TRPM5 (0.39) PKMTDP1KMT2AMEN1
SCHEMBL4659346 0.82 ALDH1A1 (0.41) LMNACA2CA1CA12CA7
Hydrochloric Acid SCHEMBL27845581 0.81 ALDH1A1 (0.40) LMNATDP1KMT2AKDM4EMEN1
SCHEMBL22951427 0.78 ALDH1A1 (0.41) LMNAPKMKMT2AKDM4EMEN1
Sulfanilamide SCHEMBL1499915 0.76 CA2 (0.52) LMNACA2CA1CA9CA12
SCHEMBL31235124 0.72 ALOX5AP (0.48) —
SCHEMBL9839080 0.71 LMNA (0.82) LMNACA2CA1PKMCA9
SCHEMBL1354208 0.71 FLT3 (0.41) LMNACA2PKMTDP1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0757674-A1 SUBSTITUTED SULFONAMIDES AS SELECTIVE $g(b) 3? AGONISTS FOR THE TREATMENT OF DIABETES AND OBESITY Merck & Co., Inc. (US) 1997-02-12 — — EP claimed
WO-1995029159-A1 SUBSTITUTED SULFONAMIDES AS SELECTIVE β3 AGONISTS FOR THE TREATMENT OF DIABETES AND OBESITY MERCK & CO., INC. (US) 1995-11-02 — — WO claimed
Send feedback